Twin Stars Shine, Leading the Future | Getein Biotech’s Vietnam Exhibition & Investment Promotion Conference

PHARMED & HEALTHCARE VIETNAM 2025

From September 24 to 27 (Vietnam time), the highly anticipated PHARMED & HEALTHCARE VIETNAM 2025 was grandly held in Ho Chi Minh City. During the exhibition, Getein Biotech, together with its local distributor, successfully hosted an investment promotion conference on September 26. The event was bustling with attendees and lively discussions, fully demonstrating Getein Biotech’s growing brand influence and strong appeal in the Vietnamese market.

Professional Strength on Display, Booth in the Spotlight

On site, visitors engaged in in-depth discussions with Getein Biotech’s technical experts on product performance, clinical application scenarios, and potential cooperation models, highlighting the strong market recognition of Getein Biotech’s technological strength and brand value.

Seizing Industry Transformation, Sharing the China Experience

At the concurrently held investment promotion conference, a new regulation concerning the future of medical laboratories in Vietnam became the central topic of discussion.With the full implementation of Vietnam’s Regulation No. 2429/QD-BYT, all medical laboratories are now facing unprecedented quality assessment standards. The regulation clearly stipulates that laboratories failing to meet the required standards will have their testing qualifications suspended. This poses significant challenges for medical institutions at all levels in Vietnam, making the standardization and quality system upgrade of laboratories an urgent priority.

In response to this urgent market demand, the Getein Biotech team presented a precise and comprehensive solution. Matt Hu, Head of the Vietnam Market, gave attendees a detailed overview of Getein Biotech’s product portfolio, leaving a strong impression with its powerful integration capabilities. Following this, Ouna Wang, Head of Marketing for the Special Zone, analyzed the current industry landscape—offering not only an in-depth interpretation of the regulatory challenges but also a systematic sharing of valuable experience from China, where Getein Biotech has helped hundreds of laboratories achieve standardization and automation in line with international benchmarks such as ISO 15189. This series of insights directly addressed key industry pain points, providing Vietnamese laboratories—now at a turning point of transformation—with clear solutions and sparking strong resonance among the many physicians and laboratory managers in attendance.

Value-Driven Partnerships, Core Products Earn Trust

The enthusiastic response from the market serves as the strongest proof of product value. At the summit, Mr. Chinh, a local distributor in Vietnam, shared his experience, placing the spotlight on the core product lines represented by MAGICL 6000/6000i and Metis 6000. Drawing on real-world operational cases from the Vietnamese market, he vividly illustrated the outstanding performance of these instruments and the positive feedback from end users, allowing other potential partners present to clearly see the tremendous market potential.

• Outstanding Performance: Providing accurate and reliable support for clinical diagnostics.

• Comprehensive Menu: Fully meeting diverse clinical testing needs.

• Flexible Model: Offering broad possibilities for win-win collaboration.

  

  On-site partners expressed strong confidence in Getein’s market strategy, growth potential, and the strength of its core products in Vietnam. Several organizations immediately conveyed their intentions for deeper collaboration, aiming to achieve a brand-channel win-win during the rapid growth phase of Vietnam’s in-vitro diagnostics market.

  Building on this high recognition and enthusiastic cooperation, MAGICL 6000/6000i and Metis 6000 are now powering a new chapter in the Vietnamese market as a driving force.

  

Deepening Roots in Vietnam, Creating the Future Together

The successful conclusion of this exhibition and investment promotion conference marks an important milestone in Getein Biotech’s deepening presence in the Vietnamese market. We not only gained a clear understanding of the market’s real needs but also earned the steadfast confidence of our partners.

Looking ahead, Getein Biotech will continue to invest resources, leveraging leading technology and market-oriented localized services to work hand in hand with all partners, jointly driving the robust development of precision diagnostics in Vietnam.